Information Provided By:
Fly News Breaks for March 12, 2018
TARO
Mar 12, 2018 | 07:09 EDT
H.C. Wainwright analyst Raghuram Selvaraju started Taro Pharmaceutical with a Buy rating and $124 price target. The stock has "now reached a nadir" and should "gradually begin a climb" on new generic launches as well as novel branded products, the analyst contends.
News For TARO From the Last 2 Days
There are no results for your query TARO